Organizational Change Designed to Drive Strong Growth and Advance Global Commercial Focus
Company Updates Second Quarter 2023 Revenue Guidance
REDWOOD CITY, Calif., June 5, 2023 /PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that Greg Siller has been appointed Senior Vice President and Chief Commercial Officer of Nevro, effective June 19, 2023. Mr. Siller replaces Niamh Pellegrini, who will be leaving the organization effective June 9. The company also announced that in conjunction with this appointment, it is updating its revenue guidance for the second quarter of 2023 to a range of $106 to $108 million and plans to update its annual guidance when it reports its second quarter 2023 financial results.
Read more at prnewswire.com